GO:0061605 molybdopterin-synthase adenylyltransferase activity

Molybdenum cofactor (Moco) is a complex prosthetic group required for the catalytic activity of several essential enzymes, including sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The biosynthesis of Moco involves a series of conserved steps, one of which is the adenylylation of the molybdopterin-synthase sulfur-carrier protein. This reaction is catalyzed by an enzyme with molybdopterin-synthase adenylyltransferase activity, encoded by GO:0061605. Understanding this activity is crucial because it represents a key activation step in the Moco pathway, and its dysfunction leads to molybdenum cofactor deficiency, a rare but devastating metabolic disorder. The adenylyltransferase activity specifically transfers an adenylate moiety from ATP to the Gly-Gly motif of the sulfur-carrier protein, forming a protein-AMP intermediate. This modification is a prerequisite for the subsequent transfer of sulfur to molybdopterin, ultimately yielding the active Moco. The enzyme is structurally related to other adenylyltransferases involved in cofactor biosynthesis, such as those in NAD metabolism, highlighting a common mechanistic theme. For researchers, GO:0061605 provides a molecular handle to study Moco biosynthesis, to dissect disease mechanisms, and to develop therapeutic strategies. This article synthesizes current knowledge from authoritative sources and outlines experimental approaches, including CRISPR-based models, to investigate this activity.

Molybdopterin-synthase adenylyltransferase activity (GO:0061605) is defined as the catalysis of the reaction: ATP + [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly = diphosphate + [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly-AMP. In other words, it is the enzyme activity that attaches an AMP group to a specific glycine-glycine motif on the sulfur-carrier protein, using ATP as the donor. This adenylylation activates the carrier protein for subsequent sulfur transfer in molybdenum cofactor biosynthesis.

Molybdopterin-synthase adenylyltransferase activity is a critical step in the biosynthesis of the molybdenum cofactor, without which essential metabolic enzymes such as sulfite oxidase and xanthine dehydrogenase are inactive. This activity ensures that the sulfur-carrier protein is properly activated to receive sulfur, a prerequisite for Moco maturation. Defects in this process cause molybdenum cofactor deficiency, a severe disorder characterized by neurological damage and early death. Thus, understanding this activity offers insights into fundamental metabolic pathways and provides a target for diagnosing and potentially treating related diseases.

The following genes and proteins are involved in molybdopterin-synthase adenylyltransferase activity and the broader molybdenum cofactor biosynthesis pathway.

The activity of molybdopterin-synthase adenylyltransferase is likely regulated at multiple levels, including gene expression and post-translational modifications, though specific regulatory mechanisms are not fully defined. In bacteria, the moa operon is regulated by molybdenum availability and other factors. In eukaryotes, MOCS3 expression may be coordinated with other Moco biosynthesis genes. Further research is needed to elucidate precise regulatory pathways.

Mutations in genes encoding components of the Moco biosynthesis pathway, including the adenylyltransferase MOCS3 and the sulfur-carrier protein MOCS2, cause molybdenum cofactor deficiency. This disorder presents with severe neurological symptoms, seizures, and early death. The deficiency leads to loss of activity of all Moco-dependent enzymes, resulting in accumulation of sulfite and other toxic metabolites. Understanding the adenylylation step is crucial for diagnosing and potentially treating this condition.

Isolated sulfite oxidase deficiency, caused by mutations in SUOX, shares clinical features with Moco deficiency but is not directly caused by defects in adenylyltransferase activity. However, proper Moco biosynthesis, including adenylylation, is required for sulfite oxidase function. Thus, studying GO:0061605 helps delineate the pathway and its impact on sulfite oxidase-related pathologies.

Moco-dependent enzymes are critical for brain function, and defects in Moco biosynthesis lead to neurodevelopmental impairments. The adenylyltransferase activity is essential for Moco maturation, and its disruption may contribute to neuronal dysfunction. Research using model organisms and patient-derived cells can elucidate the role of this activity in neurodevelopment.

Direct measurement of molybdopterin-synthase adenylyltransferase activity can be performed using recombinant enzyme and substrate proteins. The reaction can be monitored by detecting the formation of protein-AMP intermediate or the release of diphosphate. Such assays are essential for kinetic characterization and inhibitor screening.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate Moco biosynthesis or adenylyltransferase activity. For example, cells lacking MOCS3 are auxotrophic for Moco, and screens can uncover suppressors or synthetic lethal interactions. These approaches link the activity to broader cellular networks.

Mass spectrometry-based metabolomics can quantify Moco and its precursors, as well as downstream metabolites like sulfite and xanthine, in cells with altered adenylyltransferase activity. Proteomics can assess the abundance of Moco-dependent enzymes and their post-translational modifications.

X-ray crystallography and cryo-EM can provide structural insights into the adenylyltransferase and its complexes with substrates. Biophysical methods like isothermal titration calorimetry and surface plasmon resonance can measure binding affinities and conformational changes.

Researchers studying molybdopterin-synthase adenylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in Moco biosynthesis, disease pathogenesis, or cellular metabolism. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.

Molybdopterin-synthase adenylyltransferase activity (GO:0061605) is a fundamental enzymatic step in molybdenum cofactor biosynthesis, with critical implications for human health. Defects in this activity lead to severe metabolic and neurological disorders, underscoring its importance. Continued research using advanced CRISPR models and biochemical assays will further illuminate its mechanism and potential as a therapeutic target.